Skip to content

Clinical trials

Phase 2/3 Atrial Fibrillation trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Atrial Fibrillation Phase: Phase 2/3 Clear all

18 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20042
20052
20082
20131
20151
20171
20182
20191
20201
20231
20241
20251
20262

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed8
Unknown status3
Not yet recruiting2
Terminated2
Withdrawn2
Recruiting1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Boston Scientific Corporation2
ARYx Therapeutics1
Assistance Publique - Hôpitaux de Paris1
Charles University, Czech Republic1
Elpen Pharmaceutical Co. Inc.1
Hospital Ana Nery1
Hospital Universitario Getafe1
Intermountain Health Care, Inc.1
Kuopio University Hospital1
Martín Negreira Caamaño, MD, PhD1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Atrial Fibrillation18
Atrial Flutter3
Stroke2
Arrhythmias, Cardiac1
Cardiomyopathies1
Heart Failure1
Hemorrhage1
Ischemic Attack, Transient1
Ischemic Stroke1
Myocardial Infarction1

Trials

Showing 26 to 18 of 18. Each trial links to its page on Pharma Observatory.

No trials match these filters.

Try a different keyword, or clear a filter.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.